J. Binz

Identification of a nonsteroidal liver X receptor agonist through parallel array synthesis of tertiary amines.

Timothy M Willson, L. Moore, T. Willson, 2002, Journal of medicinal chemistry.

Synergistic Effects of a GPR 119 Agonist with Metformin on Weight Loss in Diet-Induced Obese Mice

Lihong Chen, Judi A McNulty, J. Binz, 2015 .

Synergistic Effects of a GPR119 Agonist with Metformin on Weight Loss in Diet-Induced Obese Mice

Lihong Chen, Judi A McNulty, J. Binz, 2015, The Journal of Pharmacology and Experimental Therapeutics.

A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat.

J. Lehmann, T. Willson, S. Kliewer, 1999, Diabetes.

Effects of the cFMS Kinase Inhibitor 5-(3-Methoxy-4-((4-methoxybenzyl)oxy)benzyl)pyrimidine-2,4-diamine (GW2580) in Normal and Arthritic Rats

T. Brodie, R. Clark, B. Han, 2008, Journal of Pharmacology and Experimental Therapeutics.

Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis.

Bryan Goodwin, S. Kliewer, T. Mansfield, 2003, The Journal of clinical investigation.

GI262570, a Peroxisome Proliferator-Activated Receptor γ Agonist, Changes Electrolytes and Water Reabsorption from the Distal Nephron in Rats

K. Brown, Baichun Yang, J. Strum, 2005, Journal of Pharmacology and Experimental Therapeutics.

The RXR agonist LG100268 causes hepatomegaly, improves glycaemic control and decreases cardiovascular risk and cachexia in diabetic mice suffering from pancreatic beta-cell dysfunction

R. M. Lightfoot, J. Weiel, J. Lenhard, 1999, Diabetologia.